Foster City, CA, United States of America

Barr E Bauer

This inventor holds 1 USPTO granted patent. Top assignee: Arris Pharmaceutical Corporation. Active years: 1997.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Barr E Bauer: Innovator in Mast-Cell Mediated Treatments

Introduction

Barr E Bauer is a notable inventor based in Foster City, CA (US). He has made significant contributions to the field of medicine, particularly in the treatment of mast-cell mediated conditions. His innovative work has led to the development of effective methods and compositions that address various inflammatory conditions.

Latest Patents

Barr E Bauer holds a patent for "Compositions and methods for treating mast-cell mediated conditions." This invention describes compounds, methods, and compositions that are effective in treating mast cell mediated inflammatory conditions, such as conjunctivitis, asthma, and allergic rhinitis. The compounds include novel mono- and di-aminomethylbenzyl, aminobenzyl, guanidylbenzyl, and benzyl tryptase inhibitors. The compositions for treating these conditions encompass oral, inhalant, and topical preparations, as well as devices that incorporate such preparations. He has 1 patent to his name.

Career Highlights

Barr E Bauer is associated with Arris Pharmaceutical Corporation, where he continues to contribute to advancements in pharmaceutical research and development. His work focuses on creating innovative solutions for complex medical issues.

Collaborations

Throughout his career, Barr has collaborated with esteemed colleagues, including Robert T Lum and Heinz W Gschwend. These partnerships have fostered a collaborative environment that enhances the development of new treatments.

Conclusion

Barr E Bauer's contributions to the field of medicine, particularly in treating mast-cell mediated conditions, highlight his innovative spirit and dedication to improving patient care. His work continues to influence the pharmaceutical industry and offers hope for those affected by these conditions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…